AKAndreas Kyriacou

Andreas Kyriacou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andreas Kyriacou has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Jonathan Sahu

    Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK

    2 shared publications
  • Andrew Horwood

    Arrhythmia Nurse Specialist Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU

    1 shared publication
  • Anna Gregory

    Arrhythmia Nurse Specialist Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU

    1 shared publication
  • Elizabeth Johnson

    Cardiac Rehabilitation Nurse Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU

    1 shared publication
  • Graeme Kirkwood

    Consultant Cardiologist and Electrophysiologist Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU

    1 shared publication
  • Hamza Zafar

    Cardiology Specialist Trainee Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU

    1 shared publication

Latest Publications

  • Open Access

    Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series

    by Mark T Mills, Thomas A Nelson, Nicholas F Kelland, Jonathan Sahu, Justin Lee, Nigel Lewis, Tarekegn Hiwot, Andreas L Kyriacou

    Background: Cardiac involvement in Anderson–Fabry disease (AFD) can lead to arrhythmia, including ventricular tachycardia (VT). The literature on radiofrequency ablation (RFA) for the treatment of VT in AFD disease is limited.Case summary: We discuss RFA of drug-refractory VT electrical storm in three males with AFD. The first patient (53 years old) had extensive involvement of the inferolateral left ventricle (LV) demonstrated with cardiac magnetic resonance imaging (CMRI), with a left ventricular ejection fraction (LVEF) of 35%. Two VT ablation procedures were performed. At the first procedure, the inferobasal endocardial LV was ablated. Furthermore, VT prompted a second ablation, where epicardial and endocardial sites were ablated. The acute arrhythmia burden was controlled but he died 4 months later despite appropriate implantable cardioverter-defibrillator therapies for VT. The second patient (67 years old) had full-thickness inferolateral involvement demonstrated with CMRI and LVEF of 45%. RFA of several endocardial left ventricular sites was performed. Over a 3-year follow-up, only brief non-sustained VT was identified, but he subsequently died of cardiac failure. Our third patient (69 years old), had an LVEF of 35%. He had RFA of endocardial left ventricular apical disease, but died 3 weeks later of cardiac failure.Discussion: RFA of drug-refractory VT in AFD is feasible using standard electrophysiological mapping and ablation techniques, although the added clinical benefit is of questionable value. VT storm in the context of AFD may be a marker of end-stage disease.


  • An exercise-based cardiac rehabilitation programme for AF patients in the NHS: a feasibility study

    by Mark Mills, Elizabeth Johnson, Hamza Zafar, Andrew Horwood, Nicola Lax, Sarah Charlesworth, Anna Gregory, Justin Lee, Jonathan Sahu, Graeme Kirkwood, et al.

    Introduction Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in adults, estimated to affect 3.29% of the population in the UK in 2016.1 The condition is strongly associated with increased cardiovascular morbidity and mortality, in addition to reduced quality of life.2 The healthcare costs of ...